Navigation Links
Fertility Centers of Illinois is Recruiting Patients for The MultiCenter Registry with Eeva™ (MERGE) Research Study
Date:11/20/2013

Chicago, IL (PRWEB) November 20, 2013

At Fertility Centers of Illinois, both the River North IVF Center and the Highland Park IVF Center began recruiting patients on November 11th for the MultiCenter Registry with Eeva (MERGE) Research Study.

“We are proud to be part of this Auxogyn sponsored clinical study utilizing the Eeva technology”, said Dr. Angeline Beltsos. “We are pleased to offer our patients the opportunity to participate in trials that can bring a deeper understanding of early embryo development to clinical practice.”

Eeva: The Early Embryo Viability Assessment Test, is an investigational test to be used by IVF laboratories to analyze early embryo development and to aid in the selection of the best embryo for transfer. At the heart of Eeva is software that was designed to assess critical differences in early embryo growth and determine an embryo’s viability and the potential for further development.

The Eeva Test was developed based on landmark research conducted at Stanford University (Wong et al. in Nature Biotechnology, 2010) which discovered that early embryo growth events can predict embryo development and reflect the underlying health of the embryo.

Auxogyn Inc. recently completed a multi-center clinical trial using Eeva with 54 patients and 758 embryos. The results from the trial supported that when embryologists used Eeva in conjunction with their traditional techniques, they were able to correctly identify non-viable embryos 86% of the time vs. only 58% of the time without using Eeva (Conaghan et al. Fertility & Sterility, May 2013).

The goal of the MERGE study (WIRB 20130148 (#11411512.0) is to record and evaluate the use of traditional embryo grading techniques combined with Eeva in the treatment of in vitro fertilization.

If you are interested in participating in this research study, please contact Fertility Centers of Illinois at (312) 222-8200, ext 23413, or FCIResearch(at)integramed(dot)com for more information.

About Fertility Centers of Illinois:
Fertility Centers of Illinois, S.C., is one of the nation's leading fertility treatment practices, providing advanced reproductive endocrinology services in the Chicago area for more than 30 years. FCI physicians, embryologists and support staff are stringently chosen based on educational background, medical skills and their ability to collaborate. With a team of 10 nationally and internationally recognized reproductive physicians who treat thousands of patients each year, the practice has earned a reputation for overcoming hard-to-solve fertility issues. FCI is dedicated to medical and clinical excellence and continues to invest in the latest technologies and research. FCI offers a comprehensive range of fertility treatment options including intrauterine insemination, in vitro fertilization, donor egg, gestational carrier, and preimplantation genetic diagnosis, as well as extensive resources to address financial and emotional needs. Fostering a culture for continuous innovation has made FCI home to the annual Midwest Reproductive Symposium which attracts experts in the field of reproductive endocrinology from around the world. FCI has 10 offices conveniently located throughout the Chicagoland area (Buffalo Grove, Chicago/River North, Crystal Lake, Glenview, Highland Park, Hoffman Estates, Lindenhurst, Warrenville, Oakbrook Terrace, and Orland Park). FCI is a member of the Attain Fertility Network which provides discounted fertility treatment programs. For more information visit http://www.fcionline.com.

About Auxogyn:
Auxogyn hopes to change the field of reproductive health by translating scientific discoveries in early embryo development into clinical tools. For more information regarding Auxogyn and Eeva, please visit http://www.auxogyn.com and eevaivf.com.

Eeva is an Investigational device. Limited by United States law to investigational use.

Read the full story at http://www.prweb.com/releases/2013fertilitiycentersofil/11infertility/prweb11345888.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Men and women receive different fertility advice following cancer diagnosis
2. Men and Women With Cancer May Receive Different Fertility Information
3. Could Fertility Drugs Make Kids Shorter?
4. Under Right Conditions, Fertility Treatment Can Equal Natural Conception Rates: Study
5. Success of fertility treatment may approach natural birth rate
6. Childless women with fertility problems at higher risk of hospitalization for psychiatric disorders
7. Heavy Coffee Intake May Affect Fertility Treatments: Study
8. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
9. Can Fertility Treatments Influence Later Breast Cancer Risk?
10. Fertility drug usage and cancer risk
11. Ovarian Transplants May Preserve Fertility in Young Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... announced their partnership to prep patients for colonoscopy at the HyGIeaCare® Center that ... 87th Ave., Miami, FL. , The HyGIeaCare® Prep, cleared by the ...
(Date:3/24/2017)... ... ... “End Time GPS”: a dauntless and enlightened study of the second-coming of Christ, ... of published author, Wesley Gerboth, a World War II veteran, with a highly-regarded reputation ... age ninety-one, he shares the Wisdom God bestowed upon him in this publication. ...
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World Health Organization ... could be four million Zika-related cases in the Americas within the next year. Lyme ... cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other ...
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) ... Road in Building 2. The clinic is the group’s second in New Braunfels and ... the company’s second New Braunfels location brings things full circle for the group, “It’s ...
(Date:3/23/2017)... ... March 23, 2017 , ... 82% of adults are unaware of the dangers that infectious bacteria ... teeth the minimum two times a day that dentists recommend. The ramifications of improper oral ... of school and adults missing 164 million hours of work each year due to dental ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 24, 2017 Research and Markets has ... U.S.: Consumer Strategies" report to their offering. ... Pain Management ... and treat their physical pain, emphasizing consumer survey analysis, including ... sufferers and adults who have selected illnesses/conditions strongly associated with ...
(Date:3/24/2017)... 2017 ShangPharma, a leading life ... drug development and discovery services, technology, and ... announced today the intent for a strategic ... consolidating the Contract Research Organizations (CRO) and ... These entities include ChemPartner Shanghai, ChemPartner Fengxian, ...
(Date:3/24/2017)... Research and Markets has announced the addition of ... to their offering. ... IPF pipeline is very strong with a total of 97 drug candidates. ... and Sanofi are involved in the development of the IPF therapeutics. The ... Phase III stage, 15 are in Phase II stage, 12 are in ...
Breaking Medicine Technology: